| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Internet and Businesses Online > Email Marketing > Best Practices in E-mail Archiving |
|
Just Other Articles - Best Practices in E-mail Archiving
With e-mails containing an astounding 83 percent of business critical data, their storage and maintenance has be According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product come an issue. Many businesses have had to either spend huge sums to retrieve lost data or pay penalty fees for ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ailing to comply with regulatory standards. Installing an e-mail archiving tool can help greatly as they offer l lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ong term and reliable storage of e-mail and provide instant and easy access. Before opting for an e-mail archiv here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ng tool, it is necessary to clearly analyze the company’s business and compliance requirements and how they appl d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro y to data retention. The information type, the archive location, and persons responsible for managing and access ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ng the various data have to be clearly defined. The e-mail archiving system must integrate with the existing sys easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi tems and be resilient to hardware, software or network failure. They must be safe against threats from viruses t nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically at can totally corrupt the entire archive if it is not protected adequately. The systems have to ensure security and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ and reliability of messages stored in the archives. They also reduce the costs to the enterprise. Best Practic ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi s in E-mail Marketing: 1. A full understanding of e-mail archiving and how it can benefit your business. 2. An ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a e-mail retention policy that suits your current business needs with properly defined retention time frames. 3. dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod Regular updates of the retention policy. 4. Consulting all of the stakeholders to ensure the right time frame i cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin s adopted for the retention of data and that no important data is lost because of the policy. 5. Categorizing d tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen cuments and defining the retention period for each classification according to the company’s regulations or norm t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel s. 6. Informing all employees about any changes in the data retention policy. 7. Keeping the policy uncomplica ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ed to ensure uniform archiving and policy compliance. 8. Making the rules about misuse of e-mails very clear to y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products employees. 9. Making the automated e-mail archive system avoid human errors and ensure ease of use. 10. Disc . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de uraging employees from creating their own archives. When these best practices in e-mail archiving are followed, elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip the company will benefit immensely.
Many firms offer services and products to help run businesses successfully tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:5 Tasks for Purchasing Teams in 2007 Small Business Email Marketing - Within Your Grasp
|